Zitate (Citations)
1 publicationsPublikationen von Forschern, die dieses Produkt verwendenBeschreibung (Description)
Rolipram is a selective inhibitor of phosphodiesterases (PDE) IV[1]. Rolipram increases intracellular cAMP and cGMP by inhibiting PDE, leading to an increase of norepinephrine, which suppresses expression of proinflammatory cytokines and other mediators of inflammation[1]. Rolipram has potential clinical significance in alleviating endogenous depression and inflammation in the central nervous system[1].
In vitro, Rolipram (10μM; 24h) significantly inhibited the basal adhesion of T lymphoblasts to ICAM-1 (intercellular adhesion molecule-1) and VCAM-1 (vascular cell adhesion molecule-1)[2]. Rolipram (10μM; 1h) significantly inhibited lipopolysaccharide (LPS)-induced upregulation and secretion of TNF-α and IL-6 in cardiac fibroblasts[3]. Rolipram (50nM; 24h) inhibited the expression of TGF‑β1 in hypertrophic fibroblasts[4].
In vivo, Rolipram (10mg/kg; i.p.) with a single dose reduced the production of IL-1β, IL-5, IL-6 and TNF-α, while increasing the levels of IL-10 in C57BL/6 mice induced by lipopolysaccharide[5]. Rolipram (1mg/kg; i.p.) acutely restored capillary perfusion in 18h in murine cecal ligation and puncture (CLP) C57BL/6 mice model[6]. Rolipram (1.25mg/kg; 10d; i.p.) attenuated cognitive decline as well as anxiety- and depression-like behaviors in the triple-transgenic mice (3×Tg-AD) harboring 3 mutant genes APPswe, Ps1M146V and tauP301L[7].
References:
[1] hu J, Mix E, Winblad B. The antidepressant and antiinflammatory effects of rolipram in the central nervous system [J]. CNS drug reviews, 2001, 7(4): 387-398.
[2] Layseca-Espinosa E, Baranda L, Alvarado-Sánchez B, et al. Rolipram inhibits polarization and migration of human T lymphocytes [J]. The Journal of investigative dermatology, 2003, 121(1): 81-87.
[3] Ji J, Liu Z, Hong X, et al. Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts [J]. BMC cardiovascular disorders, 2020, 20(1): 242.
[4] Wu L, Xu L, Chen Y, et al. Rolipram plays an anti-fibrotic effect in ligamentum flavum fibroblasts by inhibiting the activation of ERK1/2 [J]. BMC musculoskeletal disorders, 2021, 22(1): 818.
[5] Lu X, Wang J, Chen X, et al. Rolipram protects mice from gram-negative bacterium Escherichia coli-induced inflammation and septic shock [J]. Scientific reports, 2020, 10(1): 175.
[6] Holthoff J H, Wang Z, Patil N K, et al. Rolipram improves renal perfusion and function during sepsis in the mouse [J]. The Journal of pharmacology and experimental therapeutics, 2013, 347(2): 357-364.
[7] Cong Y F, Liu F W, Xu L, et al. Rolipram ameliorates memory deficits and depression-like behavior in APP/PS1/tau triple transgenic mice: involvement of neuroinflammation and apoptosis via cAMP signaling [J]. The international journal of neuropsychopharmacology, 2023, 26(9): 585-598.
Protokoll (Protocol)
| Cell experiment [1]: | |
|
Cell lines |
Cardiac fibroblasts |
|
Preparation Method |
Cardiac fibroblasts were treated with 1μg/ml lipopolysaccharide (LPS) for 6h or 10μM Rolipram for 1h before LPS stimulation. LPS was dissolved in normal saline, and Rolipram was dissolved in dimethylsulfoxide (DMSO). The TNF-ɑ, IL-6 concentrations in the supernatant of cardiac fibroblasts were measured by enzyme immunoassays. |
|
Reaction Conditions |
10μM; 1h |
|
Applications |
Rolipram significantly inhibited LPS-induced upregulation and secretion of TNF-α and IL-6. |
| Animal experiment [2]: | |
|
Animal models |
Male C57BL/6 mice |
|
Preparation Method |
Mice received vehicle or Rolipram (10mg/kg) 1h before LPS (15mg/kg; i.p.) injection. LPS was dissolved in PBS and Rolipram was dissolved in DMSO and further diluted in PBS. Blood samples were collected at 0, 3, 12, 24, and 48h after LPS injection for cytokine/chemokine assays. |
|
Dosage form |
10mg/kg; i.p. |
|
Applications |
Rolipram reduced the production of IL-1β, IL-5, IL-6 and TNF-α, while increased the levels of IL-10. |
References: [1] Ji J, Liu Z, Hong X, et al. Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts [J]. BMC cardiovascular disorders, 2020, 20(1): 242. [2] Lu X, Wang J, Chen X, et al. Rolipram protects mice from gram-negative bacterium Escherichia coli-induced inflammation and septic shock [J]. Scientific reports, 2020, 10(1): 175. | |
Produktdokumente (Product Documents)
Chemische Eigenschaften (Chemical Properties)
Verwenden Sie Stammlösungen bei Lagerung bei -80°C innerhalb von 6 Monaten bzw. bei -20°C innerhalb von 1 Monat.
Zur Verbesserung der Löslichkeit das Röhrchen auf 37°C erwärmen und für eine angemessene Dauer beschallen.
Rechner (Calculators)Molarität / Verdünnung / Molekulargewicht / Einheitenumrechnung / In-vivo-Formulierung / Löslichkeit
Reviews
Review for Rolipram
- 5 Star100%
- 4 Star0%
- 3 Star0%
- 2 Star0%
- 1 Star0%
